Theodora S. Ross - Publications

University of Michigan, Ann Arbor, Ann Arbor, MI 

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Holmstrom SR, Wijayatunge R, McCrum K, Mgbemena VE, Ross TS. Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis. Iscience. 19: 809-820. PMID 31499338 DOI: 10.1016/j.isci.2019.08.031  0.4
2018 Wijayatunge R, Holmstrom SR, Foley SB, Mgbemena VE, Bhargava V, Perez GL, McCrum K, Ross TS. Deficiency of the Endocytic Protein Leads to Decreased expression, Low Phosphocholine, and Kypholordosis. Molecular and Cellular Biology. PMID 30224518 DOI: 10.1128/MCB.00385-18  0.4
2017 Mgbemena VE, Signer RA, Wijayatunge R, Laxson T, Morrison SJ, Ross TS. Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function. Cell Reports. 18: 947-960. PMID 28122244 DOI: 10.1016/j.celrep.2016.12.075  0.4
2015 Foley SB, Rios JJ, Mgbemena VE, Robinson LS, Hampel HL, Toland AE, Durham L, Ross TS. Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic. Ebiomedicine. 2: 74-81. PMID 26023681 DOI: 10.1016/j.ebiom.2014.12.003  0.4
2015 Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, Levine B. Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. Ebiomedicine. 2: 255-263. PMID 25825707 DOI: 10.1016/j.ebiom.2015.01.008  0.44
2015 Yorczyk A, Robinson LS, Ross TS. Use of panel tests in place of single gene tests in the cancer genetics clinic. Clinical Genetics. 88: 278-82. PMID 25318351 DOI: 10.1111/cge.12488  0.44
2015 Foley SB, Rios JJ, Mgbemena VE, Robinson LS, Hampel HL, Toland AE, Durham L, Ross TS. Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic Ebiomedicine. 2: 74-81. DOI: 10.1016/j.ebiom.2014.12.003  0.44
2014 Ross TS, Mgbemena VE. Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia. Molecular & Cellular Oncology. 1: e963450. PMID 27308345 DOI: 10.4161/23723548.2014.963450  0.4
2014 Messa M, Fernández-Busnadiego R, Sun EW, Chen H, Czapla H, Wrasman K, Wu Y, Ko G, Ross T, Wendland B, De Camilli P. Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits. Elife. 3: e03311. PMID 25122462 DOI: 10.7554/eLife.03311  0.44
2014 Pritzlaff M, Yorczyk A, Robinson LS, Pirzadeh-Miller S, Lin T, Euhus D, Ross TS. An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process. Journal of Genetic Counseling. 23: 1034-44. PMID 24916850 DOI: 10.1007/s10897-014-9732-5  0.44
2014 Philips ST, Hildenbrand ZL, Oravecz-Wilson KI, Foley SB, Mgbemena VE, Ross TS. Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells. Oncogene. 33: 5379-90. PMID 24240679 DOI: 10.1038/onc.2013.484  0.44
2013 Soyombo AA, Wu Y, Kolski L, Rios JJ, Rakheja D, Chen A, Kehler J, Hampel H, Coughran A, Ross TS. Analysis of induced pluripotent stem cells from a BRCA1 mutant family. Stem Cell Reports. 1: 336-49. PMID 24319668 DOI: 10.1016/j.stemcr.2013.08.004  0.44
2013 Foley SB, Hildenbrand ZL, Soyombo AA, Magee JA, Wu Y, Oravecz-Wilson KI, Ross TS. Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. Cell Reports. 5: 51-60. PMID 24095735 DOI: 10.1016/j.celrep.2013.08.037  0.44
2013 Ames HM, Wang AA, Coughran A, Evaul K, Huang S, Graves CW, Soyombo AA, Ross TS. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases. Molecular and Cellular Biology. 33: 3580-93. PMID 23836884 DOI: 10.1128/MCB.00473-13  0.4
2011 Ames HM, Bichakjian CK, Liu GY, Oravecz-Wilson KI, Fullen DR, Verhaegen ME, Johnson TM, Dlugosz AA, Ross TS. Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit. The Journal of Investigative Dermatology. 131: 2113-20. PMID 21697888 DOI: 10.1038/jid.2011.171  0.44
2009 Oravecz-Wilson KI, Philips ST, Yilmaz OH, Ames HM, Li L, Crawford BD, Gauvin AM, Lucas PC, Sitwala K, Downing JR, Morrison SJ, Ross TS. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell. 16: 137-48. PMID 19647224 DOI: 10.1016/j.ccr.2009.06.007  0.44
2008 Jain RN, Al-Menhali AA, Keeley TM, Ren J, El-Zaatari M, Chen X, Merchant JL, Ross TS, Chew CS, Samuelson LC. Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice. The Journal of Clinical Investigation. 118: 2459-70. PMID 18535670 DOI: 10.1172/JCI33569  0.44
2008 Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS. Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues. Cancer Research. 68: 1064-73. PMID 18281481 DOI: 10.1158/0008-5472.CAN-07-5892  0.44
2007 Bradley SV, Smith MR, Hyun TS, Lucas PC, Li L, Antonuk D, Joshi I, Jin F, Ross TS. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies. Cancer Research. 67: 8923-31. PMID 17875735 DOI: 10.1158/0008-5472.CAN-07-2153  0.96
2007 Bradley SV, Hyun TS, Oravecz-Wilson KI, Li L, Waldorff EI, Ermilov AN, Goldstein SA, Zhang CX, Drubin DG, Varela K, Parlow A, Dlugosz AA, Ross TS. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1. Human Molecular Genetics. 16: 1279-92. PMID 17452370 DOI: 10.1093/hmg/ddm076  0.44
2007 Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Research. 67: 3609-15. PMID 17440072 DOI: 10.1158/0008-5472.CAN-06-4803  0.44
2005 Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J, Neal DE. Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors Journal of Cell Biology. 170: 191-200. PMID 16027218 DOI: 10.1083/jcb.200503106  0.44
2005 Bradley SV, Oravecz-Wilson KI, Bougeard G, Mizukami I, Li L, Munaco AJ, Sreekumar A, Corradetti MN, Chinnaiyan AM, Sanda MG, Ross TS. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer. Cancer Research. 65: 4126-33. PMID 15899803 DOI: 10.1158/0008-5472.CAN-04-4658  0.44
2004 Hyun TS, Li L, Oravecz-Wilson KI, Bradley SV, Provot MM, Munaco AJ, Mizukami IF, Sun H, Ross TS. Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1. Molecular and Cellular Biology. 24: 4329-40. PMID 15121852  0.96
2004 Hyun TS, Ross TS. HIP1: trafficking roles and regulation of tumorigenesis. Trends in Molecular Medicine. 10: 194-9. PMID 15059611 DOI: 10.1016/j.molmed.2004.02.003  0.96
2004 Oravecz-Wilson KI, Kiel MJ, Li L, Rao DS, Saint-Dic D, Kumar PD, Provot MM, Hankenson KD, Reddy VN, Lieberman AP, Morrison SJ, Ross TS. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts. Human Molecular Genetics. 13: 851-67. PMID 14998932 DOI: 10.1093/hmg/ddh102  0.44
2004 Hyun TS, Rao DS, Saint-Dic D, Michael LE, Kumar PD, Bradley SV, Mizukami IF, Oravecz-Wilson KI, Ross TS. HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. The Journal of Biological Chemistry. 279: 14294-306. PMID 14732715 DOI: 10.1074/jbc.M312645200  0.44
2003 Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell. 3: 471-82. PMID 12781365 DOI: 10.1016/S1535-6108(03)00107-7  0.44
2002 Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. The Journal of Clinical Investigation. 110: 351-60. PMID 12163454 DOI: 10.1172/JCI15529  0.44
2001 Rao DS, Chang JC, Kumar PD, Mizukami I, Smithson GM, Bradley SV, Parlow AF, Ross TS. Huntingtin interacting protein 1 is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors Molecular and Cellular Biology. 21: 7796-7806. PMID 11604514 DOI: 10.1128/MCB.21.22.7796-7806.2001  0.44
2001 Saint-Dic D, Chang SC, Taylor GS, Provot MM, Ross TS. Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/PDGFbeta R-transformed cells. The Journal of Biological Chemistry. 276: 21192-8. PMID 11287412 DOI: 10.1074/jbc.M008336200  0.44
1999 Ross TS, Gilliland DG. Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein Journal of Biological Chemistry. 274: 22328-22336. PMID 10428802 DOI: 10.1074/jbc.274.32.22328  0.44
1998 Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaia R, Marynen P, Gilliland DG. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes Embo Journal. 17: 5321-5333. PMID 9736611 DOI: 10.1093/emboj/17.18.5321  0.44
1990 Ross TS, Tait JF, Majerus PW. Identity of inositol 1,2-cyclic phosphate 2-phosphohydrolase with lipocortin III Science. 248: 605-607. PMID 2159184  0.44
1987 Brandley BK, Ross TS, Schnaar RL. Multiple carbohydrate receptors on lymphocytes revealed by adhesion to immobilized polysaccharides Journal of Cell Biology. 105: 991-997. PMID 3040775  0.44
Show low-probability matches.